RDNT vs ZBH
RadNet, Inc. vs Zimmer Biomet — AI-powered side-by-side comparison
RDNT
RadNet, Inc.
52
Watch
VS
| Metric | RDNT | ZBH |
|---|
| AI Score |
52
|
69
|
| Price |
$76.28
|
$97.22
|
| P/E Ratio |
-286.45×
|
23.54×
|
| ROE |
-1.7%
|
5.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
9.7%
|
69.9%
|
| Debt / Equity |
1.99×
|
0.59×
|
| Dividend Yield |
0.0%
|
1.0%
|
| RSI (14) |
78.1
|
63.1
|
| Beta |
1.384
|
0.462
|
| Expected Upside |
—
|
+3.7%
|
AI Committee View
Current Innellis committee reasoning for RDNT versus ZBH.
ZBH leads by 17 points.
ZBH scores 69/100 (Buy) versus RDNT at 52/100 (Watch).
RDNT Committee View
33% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — price-to-book of 5.1x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price-to-book of 5.1x prices in significant intangible value — Value
- ROE of only -1.4% -- cheap may mean cheap for a reason — Value
- RSI at 78 is in overbought territory — Technical
ZBH Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.
Bull Case
- Price-to-book of 1.4x is a discount to asset value — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical